The Drug Tariff Category M pricelist for October 2024 has been published on the NHS Business Services Authority (NHSBSA) website. The new October Category M prices include an adjustment for margin of -£9m per quarter, resulting from the combination of: An adjustment informed by the latest results from the margin survey of independent pharmacies An [...]
The post October 2024 Category M prices announced appeared first on Community Pharmacy England.
The 2023/24 Annual Report for Community Pharmacy England has been published, setting out the range of work that has been done over the past year on behalf of all community pharmacy owners. This included negotiations on the new Pharmacy First service and support for pharmacy owners with national services; ongoing work to monitor margin [...]
The post Our Annual Report 2023/24 appeared first on Community Pharmacy England.
The ability of pharmacy owners to achieve the thresholds for the monthly Pharmacy First payment has been an ongoing topic of great concern for pharmacy owners and Community Pharmacy England, particularly as the October increase to 30 clinical pathways got closer. We have been discussing this issue over the last few weeks with the Department [...]
The post Change to October Pharmacy First monthly threshold appeared first on Community Pharmacy England.
Drug alert number: EL (24)A/44 Date issued: 30 September 2024 Pfizer Limited is recalling all distributed batches of Oxbryta 500 mg Tablets. Pfizer Limited has informed the MHRA that the product is being withdrawn due to emerging data from clinical trials and registry-based studies: Oxbryta (voxelotor) 500mg Tablets (Pfizer Limited) PLGB 00057/1720 DMRC Number: DMRC-32749585 [...]
The post MHRA Class 2 Medicines Recall: Oxbryta (voxelotor) 500mg Tablets (Pfizer Limited) appeared first on Community Pharmacy England.
From next week, Tuesday 1 October, references will no longer be required for market entry applications. This followed concerns raised by Community Pharmacy England that they offered little value to the process and contributed to delays. The changes are included in The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2024 [...]
The post Market Entry application change – no references required appeared first on Community Pharmacy England.
Recent Comments